Close Alert Banner
Skip to Content
Visit BORNOntario.caVisit BORN.ca
COVID-19: Information for PregnancyContact Us
FR

BORN Ontario Logo

Contact Us icon
  • What is Prenatal Screening?
    • What Do We Screen For?
    • Multiple Marker Screening (MMS)
    • Non-Invasive Prenatal Testing
    • Nuchal Translucency Ultrasound
    • Options by Pregnancy Stage
    • For Twins or More Than Two Babies
    • Nominate a Condition
  • Results and Next Steps
    • Multiple Marker Screening (MMS) Results
    • Non-invasive Prenatal Testing (NIPT) Results
    • Diagnostic Testing
  • Requisitions and Provider Tools
    • Multiple Marker Screening (MMS) Requisitions
    • Non-invasive Prenatal Testing (NIPT) Requisitions
    • Provider Tools
  • For Sonographers
    • NT Registration
    • Log in to the BIS
    • NT Quality Assurance
    • Resources and Point of Care Tools
    • Facilities that offer Nuchal Translucency ultrasound
  • About Us
    • Contact Us
    • Careers
    • Events Calendar
    • Get Involved
    • PSO News
    • Subscribe to PSO updates
HomeWhat is Prenatal Screening?What Do We Screen For?Trisomy 13
  • Open new window to share this page via Facebook Facebook
  • Open new window to share this page via LinkedIn LinkedIn
  • Open new window to share this page via Twitter Twitter
  • Email this page Email

Trisomy 13

Trisomy refers to a person having three copies of a chromosome, instead of the typical two. Trisomy 13 (also called Patau syndrome), is a condition that is caused by an extra copy of chromosome 13 due to an error in cell division that occurs very early in pregnancy.  This extra copy of chromosome 13 is usually found in every cell of a person's body. Trisomy 13 typically occurs by chance; there isn't anything a person does or does not do, to cause this condition. When a person has an extra chromosome 13, it disrupts the typical pattern of development resulting in a severe, life-limiting condition with physical abnormalities affecting many different parts of the body.

Trisomy 13 karyotype

trisomy 13 karyotype

Illustration adapted from Genetic Counseling Aids, 7th Edition, Copyright 2020, permission for use granted by Greenwood Genetic Center

Types of trisomy 13

Trisomy 13

Most cases of trisomy 13 result from an individual having three copies of chromosome 13 in every cell of their body instead of the usual two copies. This type of trisomy 13 is typically not inherited.

Mosaic trisomy 13

Some individuals with trisomy 13 have an extra copy of chromosome 13 in only some of the body's cells. These individuals have a mixture of cells, some having two copies of chromosome 13 and some having three copies. The impact of having this extra chromosome 13 on a baby's development varies widely and depends on the number of cells that have this extra genetic material Like trisomy 13, mosaic trisomy 13 is not inherited.

Translocation trisomy 13

In individuals with a translocation form of trisomy 13, part of chromosome 13 becomes attached (translocated) to another chromosome. Affected individuals have two separate copies of chromosome 13 plus extra material from chromosome 13 attached to another chromosome, resulting in three copies of genetic material from chromosome 13. This type of trisomy 13 occurs less commonly and can sometimes be inherited from a healthy parent.

The incidence of trisomy 13

Trisomy 13 occurs in 1 in 6,000 to 1 in 29,000 live births. The overall prevalence is higher in pregnancy because many babies with trisomy 13 will miscarry before delivery. Although a pregnant person could have a baby with trisomy 13 at any age, the chance increases with maternal age. 

Features of trisomy 13

The extra chromosome 13 can affect the development of each baby differently. In general, babies with trisomy 13 have severe intellectual disabilities and can have birth defects in almost every organ system in their body. Some common features include:

  • Holoprosencephaly (failure of the brain to divide properly)
  • Heart defects
  • Kidney abnormalities
  • Spina bifida
  • Omphalocele (sac attached to the abdomen)
  • Cleft lip and/or palate
  • Polydactyly (extra fingers or toes)
  • Eye abnormalities (small or absent eyes)
  • Cutis aplasia (missing skin on the scalp)

Life expectancy

The life expectancy of babies with trisomy 13 is difficult to determine however it is estimated that the 50% of babies with trisomy 13 survive past the first week of life, and approximately 10% of children live beyond the first year.  

Next steps

You may be hearing about trisomy 13 because your prenatal screening test (eFTS, MSS, NIPT) was positive or high risk for having a baby with trisomy 13. If this is the case, your health care provider should offer to refer you for genetic counselling to review your test results and your options for additional testing.

Additional resources

  • Regional Genetics Centres
  • Genetics Home Reference
  • SOFT – Support Organization for Trisomy 13, 18 and related disorders
  • International Trisomy 13/18 Alliance

Sources for this page

Peroos S, Forsythe E, Pugh JH, Arthur-Farraj P, Hodes D. Longevity and Patau syndrome: what determines survival?. BMJ Case Rep. 2012

U.S. National Library of Medicine. Genetics home reference [Internet]. Bethesda (MD): U.S. National Library of Medicine; 2017. 

  • What is Prenatal Screening?
    • What Do We Screen For?
      Toggle Section What Do We Screen For? Menu
      • Trisomy 21 (Down syndrome)
      • Trisomy 18
      • Trisomy 13
      • Sex chromosome differences
    • Multiple Marker Screening (MMS)
      Toggle Section Multiple Marker Screening (MMS) Menu
      • Enhanced First Trimester Screening (eFTS)
      • Maternal Serum Screen (MSS)
    • Non-Invasive Prenatal Testing
      Toggle Section Non-Invasive Prenatal Testing Menu
      • NIPT Funding Criteria
    • Nuchal Translucency Ultrasound
      Toggle Section Nuchal Translucency Ultrasound Menu
      • Increased Nuchal Translucency
    • Options by Pregnancy Stage
      Toggle Section Options by Pregnancy Stage Menu
      • Less than 14 Weeks' Pregnant
      • 14-21 Weeks' Pregnant
      • Greater than 21 Weeks' Pregnant
    • For Twins or More Than Two Babies
    • Nominate a Condition

Contact Us

Subscribe to this page

Prenatal Screening Ontario logo

BORN Ontario logo

Our Website

  • What is Prenatal Screening?
  • Results and Next Steps
  • Requisitions and Provider Tools
  • For Sonographers
  • About Us

Helpful Links

  • Contact Us
  • Sitemap
  • Website Feedback
  • View our Facebook Page
  • View our Twitter Page

Contact Us

Prenatal Screening Ontario 
CHEO Research Institute 
Centre for Practice-Changing Research Building 
401 Smyth Road 
Ottawa, ON K1H 8L1

Phone: 613-737-2281

Toll-Free: 1-833-351-6490

Monday to Friday, 9:00 AM to 3:00 PM

Copyright © 2022 BORN Ontario | Funded by the Government of Ontario

Designed by eSolutionsGroup

Close Old Browser Notification
Browser Compatibility Notification
It appears you are trying to access this site using an outdated browser. As a result, parts of the site may not function properly for you. We recommend updating your browser to its most recent version at your earliest convenience.